Cardiac 123I-MIBG uptake in idiopathic ventricular tachycardia and fibrillation.

UNLABELLED Patients with idiopathic ventricular tachycardia or fibrillation have no additional structural or functional myocardial abnormalities. However, the inducibility of typical tachyarrhythmias by physical or mental stress or by catecholamine infusion suggests the involvement of the adrenergic system in the pathogenesis of these potentially life-threatening diseases. METHODS 45 patients with idiopathic right ventricular outflow tract tachycardia (RVO-VT), 25 patients with idiopathic left ventricular tachycardia (ILVT), 15 patients with idiopathic ventricular fibrillation (IVF) and 10 age-matched control patients were investigated in this study. Diagnoses were made on the basis of detailed evaluation of the results of two-dimensional echocardiography, left and right ventricular angiography, coronary angiography and endomyocardial biopsy. Local presynaptic norepinephrine re-uptake was assessed using the norepinephrine analog 1231-metaiodobenzylguanidine (MIBG), SPECT and semiquantitative 33-segment bull's-eye analysis. RESULTS Locally reduced 123I-MIBG uptake was found in 27 of 45 RVO-VT patients (60%), 5 of 15 ILVT patients (33%) and 17 of 25 IVF patients (68%). Unlike ILVT patients, RVO-VT and IVF patients had significantly reduced segmental 123I-MIBG uptake of the posterior wall compared with control patients. CONCLUSION Patients with idiopathic tachycardia and fibrillation show abnormal 1231-MIBG uptake, which indicates presynaptic sympathetic dysfunction. RVO-VT and IVF patients exhibit significantly reduced 123I-MIBG uptake in the posterior left ventricular wall, whereas ILVT patients do not.

[1]  H. Calkins,et al.  Scintigraphic Pattern of Regional Cardiac Sympathetic Innervation in Patients With Familial Long QT Syndrome Using Positron Emission Tomography , 1993, Circulation.

[2]  G. Breithardt,et al.  Catheter ablation of idiopathic right ventricular tachycardia. , 1990, Circulation.

[3]  S. Ikeda,et al.  Iodine-123-metaiodobenzylguanidine myocardial imaging in patients with right ventricular pressure overload. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[4]  G. Breithardt,et al.  Standards for analysis of ventricular late potentials using high resolution or signal-averaged electrocardiography. A statement by a Task Force Committee between the European Society of Cardiology, the American Heart Association and the American College of Cardiology. , 1991, European heart journal.

[5]  S. Vatner,et al.  Myocardial beta-adrenergic receptor function during the development of pacing-induced heart failure. , 1993, The Journal of clinical investigation.

[6]  S. Amara,et al.  Evaluation of metaiodobenzylguanidine uptake by the norepinephrine, dopamine and serotonin transporters. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[7]  A. Camm,et al.  Asymmetry of cardiac [1231] meta-iodobenzyl-guanidine scans in patients with ventricular tachycardia and a "clinically normal" heart , 2022 .

[8]  G. Breithardt,et al.  Efficacy of Antiarrhythmic Drugs in Patients With Arrhythmogenic Right Ventricular Disease: Results in Patients With Inducible and Noninducible Ventricular Tachycardia , 1992, Circulation.

[9]  E. Kleinhans,et al.  Three-Dimensional ROI-Based Quantification of Stress/Rest 201TI Myocardial SPECT: Presentation of Method , 1986, Nuklearmedizin.

[10]  M. Kienzle,et al.  Effect of direct, reflex and exercise-provoked increases in sympathetic tone on idiopathic ventricular tachycardia. , 1992, The American journal of cardiology.

[11]  S. Markowitz,et al.  Mechanisms of Idiopathic Left Ventricular Tachycardia , 1997, Journal of cardiovascular electrophysiology.

[12]  I. Narabayashi,et al.  Iodine-123 metaiodobenzylguanidine myocardial scintigraphy for prediction of response to beta-blocker therapy in patients with dilated cardiomyopathy. , 1997, American heart journal.

[13]  S. Viskin,et al.  Idiopathic Ventricular Tachycardia and Fibrillation , 1993, Journal of cardiovascular electrophysiology.

[14]  G. Breithardt,et al.  Cardiac sympathetic innervation in patients with idiopathic right ventricular outflow tract tachycardia. , 1998, Journal of the American College of Cardiology.

[15]  G. Breithardt,et al.  Regional Myocardial Sympathetic Dysinnervation in Arrhythmogenic Right Ventricular Cardiomyopathy: An Analysis Using 123I‐Meta‐Iodobenzylguanidine Scintigraphy , 1994, Circulation.

[16]  S. Viskin,et al.  Idiopathic ventricular fibrillation. , 1990, American heart journal.

[17]  M. Böhm,et al.  Evidence for reduction of norepinephrine uptake sites in the failing human heart. , 1995, Journal of the American College of Cardiology.

[18]  D. Battleman,et al.  Mechanism of repetitive monomorphic ventricular tachycardia. , 1995, Circulation.

[19]  J. Bomanji,et al.  A pharmacological guide to medicines which interfere with the biodistribution of radiolabelled meta-iodobenzylguanidine (MIBG). , 1992, Nuclear medicine communications.

[20]  J. Delcán,et al.  Idiopathic Ventricular Tachycardia and Fibrillation: Incidence, Prognosis, and Therapy , 1992, Pacing and clinical electrophysiology : PACE.

[21]  D. Zipes Sympathetic stimulation and arrhythmias. , 1991, The New England journal of medicine.

[22]  Y. Nakaya,et al.  [Idiopathic ventricular fibrillation]. , 1996, Ryoikibetsu shokogun shirizu.

[23]  V Hombach,et al.  Standards for analysis of ventricular late potentials using high-resolution or signal-averaged electrocardiography: a statement by a task force committee of the European Society of Cardiology, the American Heart Association, and the American College of Cardiology. , 1991, Journal of the American College of Cardiology.

[24]  C. Reiners,et al.  Effect of specific activity on cardiac uptake of iodine-123-MIBG. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[25]  A. Weikl,et al.  Congenital Myocardial Sympathetic Dysinnervation (CMSD)—A Structural Defect of Idiopathic Long QT Syndrome , 1991, Pacing and clinical electrophysiology : PACE.

[26]  J. Sisson,et al.  Metaiodobenzylguanidine as an index of the adrenergic nervous system integrity and function. , 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[27]  H Kasanuki,et al.  Idiopathic ventricular fibrillation induced with vagal activity in patients without obvious heart disease. , 1997, Circulation.

[28]  G. Breithardt,et al.  Pathophysiological mechanisms of ventricular tachyarrhythmias. , 1989, European heart journal.

[29]  S. Sumita,et al.  123I-MIBG myocardial imaging in hypertensive patients: Abnormality progresses with left ventricular hypertrophy , 1996, Annals of nuclear medicine.